Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Cleft Palate D002972 9 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Contusions D003288 3 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Coronary Vasospasm D003329 9 associated lipids
Cough D003371 19 associated lipids
Death, Sudden D003645 12 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Diseases in Twins D004200 4 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Rocca B et al. Increased thromboxane biosynthesis in essential thrombocythemia. 1995 Thromb. Haemost. pmid:8607099
Cochran JB et al. Age-related mortality and adherent splenic cell mediator production to endotoxin in the rat. 1995 Shock pmid:8608403
Kritz H et al. Isradipine increases vascular prostaglandin I2-formation while the thromboxane B2-synthesis is diminished. 1995 Thromb. Res. pmid:8610276
Aune B et al. Hormone replacement therapy reduces the reactivity of monocytes and platelets in whole blood--a beneficial effect on atherogenesis and thrombus formation? 1995 Am. J. Obstet. Gynecol. pmid:8610768
Osterud B et al. Effect of marine oils supplementation on coagulation and cellular activation in whole blood. 1995 Lipids pmid:8614301
Awni WM et al. The pharmacokinetic and pharmacodynamic interactions between the 5-lipoxygenase inhibitor zileuton and the cyclo-oxygenase inhibitor naproxen in human volunteers. 1995 Clin Pharmacokinet pmid:8620667
Praticó D and FitzGerald GA Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. 1996 J. Biol. Chem. pmid:8621535
Hirashima Y et al. Prevention of cerebrovasospasm following subarachnoid hemorrhage in rabbits by the platelet-activating factor antagonist, E5880. 1996 J. Neurosurg. pmid:8622157
Korn RL et al. The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation. 1996 J. Thorac. Cardiovasc. Surg. pmid:8622305
McAdam B et al. Transdermal modification of platelet function: an aspirin patch system results in marked suppression of platelet cyclooxygenase. 1996 J. Pharmacol. Exp. Ther. pmid:8627531
Jacoby RF et al. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. 1996 Cancer Res. pmid:8631000
Suehiro T et al. Thromboxane A2 in preservation-reperfusion injury: the effect of thromboxane A2 synthetase inhibitor. 1996 J. Surg. Res. pmid:8632642
Garvin PJ et al. Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model. 1996 Transplantation pmid:8633364
Thwaites BK et al. Intravenous ketorolac tromethamine worsens platelet function during knee arthroscopy under spinal anesthesia. 1996 Anesth. Analg. pmid:8638787
Saji T et al. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension]. 1996 J Cardiol pmid:8642506
Leung LK and Glauert HP Reduction of the concentrations of prostaglandins E2 and F2alpha, and thromboxane B2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate. 1996 Toxicol. Lett. pmid:8644126
Ikemura T et al. KW-4679, an antiallergic drug, inhibits the production of inflammatory lipids in human polymorphonuclear leukocytes and guinea pig eosinophils. 1996 Int. Arch. Allergy Immunol. pmid:8645979
Dehmlow C et al. Scavenging of reactive oxygen species and inhibition of arachidonic acid metabolism by silibinin in human cells. 1996 Life Sci. pmid:8649189
Wahle KW and Peacock LI Effects of isomeric cis and trans eighteen carbon monounsaturated fatty acids on porcine platelet function. 1996 Biochim. Biophys. Acta pmid:8652649
Haimovich B et al. The FcgammaRII receptor triggers pp125FAK phosphorylation in platelets. 1996 J. Biol. Chem. pmid:8663117
Saitta A et al. Effects of gallopamil on epinephrine and norepinephrine plasmatic levels and on TxB2 and beta-tg release in patients with coronary artery disease during adrenergic stimulus with cold pressor test. 1995 Jul-Aug Pharmacol. Res. pmid:8668647
Stein CM et al. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. 1996 Arthritis Rheum. pmid:8670323
Myers SI et al. Regulation of eicosanoid synthesis in fibroblasts from inflamed gallbladders. 1995 Mol. Cell. Endocrinol. pmid:8674862
Tsunomori M et al. 15-Hydroperoxyeicosapentaenoic acid inhibits arachidonic acid metabolism in rabbit platelets more potently than eicosapentaenoic acid. 1996 Biochim. Biophys. Acta pmid:8679681
Delatour P et al. Pharmacodynamics and chiral pharmacokinetics of carprofen in calves. 1996 Br. Vet. J. pmid:8680841
Cervar M et al. Altered release of endothelin-1,2 and thromboxane B2 from trophoblastic cells in pre-eclampsia. 1996 Eur. J. Clin. Invest. pmid:8682152
Taylor PM et al. Pharmacodynamics and enantioselective pharmacokinetics of carprofen in the cat. 1996 Res. Vet. Sci. pmid:8685536
Malý J et al. Migraine--a haematological disorder? 1995 Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove pmid:8685625
Takase B et al. Arachidonic acid metabolites in acute myocardial infarction. 1996 Angiology pmid:8686958
Jensen N et al. Recovery of endothelial cells and prostanoid production in endothelial cell-seeded grafts. 1996 Eur J Vasc Endovasc Surg pmid:8696898
Nosál R et al. The H1-histamine antagonist Dithiaden inhibits human platelets in vitro. 1996 Inflamm. Res. pmid:8696916
Sun B et al. [The experimental observation on the procedure of atherosclerotic restenosis following PTCA]. 1995 Zhonghua Nei Ke Za Zhi pmid:8697911
Liu H et al. [Effects of low dose aspirin on platelet function and prostaglandins metabolism in systemic and coronary circulation in patients with ischemia heart disease]. 1995 Zhonghua Nei Ke Za Zhi pmid:8697924
Howarth SR et al. Role of thromboxane A2 in the vasoconstrictor response to endothelin-1, angiotensin II and 5-hydroxytryptamine in human placental vessels. 1995 Placenta pmid:8710799
Herrick AL et al. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. 1996 Ann. Rheum. Dis. pmid:8712862
Tishler M et al. Salivary eicosanoid concentration in patients with Sjögren's syndrome. 1996 Ann. Rheum. Dis. pmid:8712887
Oláh L et al. [Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke]. 1996 Orv Hetil pmid:8714038
Kruse-Elliott KT et al. Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist. 1996 Shock pmid:8721386
Yanase T et al. Dibutyryl cAMP improves systemic vasoconstriction caused by endotoxin in dogs. 1996 Shock pmid:8721389
Grauer GF et al. Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs. 1996 Am. J. Vet. Res. pmid:8725828
Isozaki H et al. Urinary thromboxane B2 as an indicator of acute rejection in human liver transplantation. 1996 Surg. Today pmid:8727944
Xiong YL and Zhao HY Effect of captopril on antithrombus function of endothelium. 1995 J. Tongji Med. Univ. pmid:8731927
Xiong YL and Zhao HY Experimental studies on preventive effects of API0134 on vessel reocclusion after thrombolysis. 1995 J. Tongji Med. Univ. pmid:8731957
Liang XC et al. [Study on relationship of lipid peroxide in coronary heart disease with and without diabetes]. 1996 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:8732128
Liang-min LD et al. [Effect of age on hemostasis and plasma level of TXB2 and 6-keto-PGF1 alpha]. 1995 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:8732148
Li H [Research on plasma TXA2, PGI2 levels, blood stasis syndrome and promoting blood circulation]. 1995 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:8732157
Cheng Z et al. Pharmacokinetics and pharmacodynamics of phenylbutazone and oxyphenbutazone in the donkey. 1996 J. Vet. Pharmacol. Ther. pmid:8735424
Jancinová V et al. Inhibition of blood platelet functions by cationic amphiphilic drugs in relation to their physico-chemical properties. 1996 Blood Coagul. Fibrinolysis pmid:8735816
Lechi C et al. In vitro study of the anti-aggregating activity of two nitroderivatives of acetylsalicylic acid. 1996 Blood Coagul. Fibrinolysis pmid:8735820
Ravn HB et al. Magnesium inhibits human platelets. 1996 Blood Coagul. Fibrinolysis pmid:8735829